The document provides guidelines on personal protective equipment for donning and removing PPE, airborne precautions for certain diseases, recommendations for live and inactivated vaccines, cancer screening guidelines, folic acid sources, triage assessments for conditions like increased intracranial pressure and cardiac tamponade, risk factors for adverse drug reactions, and summaries of treatments for conditions like tuberculosis, depression, cystitis, and pyelonephritis.
The document provides guidelines on personal protective equipment for donning and removing PPE, airborne precautions for certain diseases, recommendations for live and inactivated vaccines, cancer screening guidelines, folic acid sources, triage assessments for conditions like increased intracranial pressure and cardiac tamponade, risk factors for adverse drug reactions, and summaries of treatments for conditions like tuberculosis, depression, cystitis, and pyelonephritis.
The document provides guidelines on personal protective equipment for donning and removing PPE, airborne precautions for certain diseases, recommendations for live and inactivated vaccines, cancer screening guidelines, folic acid sources, triage assessments for conditions like increased intracranial pressure and cardiac tamponade, risk factors for adverse drug reactions, and summaries of treatments for conditions like tuberculosis, depression, cystitis, and pyelonephritis.
The document provides guidelines on personal protective equipment for donning and removing PPE, airborne precautions for certain diseases, recommendations for live and inactivated vaccines, cancer screening guidelines, folic acid sources, triage assessments for conditions like increased intracranial pressure and cardiac tamponade, risk factors for adverse drug reactions, and summaries of treatments for conditions like tuberculosis, depression, cystitis, and pyelonephritis.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1/ 5
IVF CDC Guidelines:
ISOTONIC: DONNING: - NS 0.9%, LR, D5W, D5 NS 1. Gown - Stays in the vascular space 2. Mask HYPOTONIC: 3. Goggles/faceshield - D2.5W, 0.5% NS, 0.33% NS 4. Gloves - Goes out of the vascular space REMOVING: HYPERTONIC: 1. Gloves - 3% NS, 5% NS, D5LR, D5 NS, D5NS, TPN, 2. Goggles Albumin 3. Gown - Stays and adds more in the vascular 4. Mask space
AIRBORNE CANCER SIGNS (MTV) (CAUTION) Measles C-hange in bowel/bladder habit TB A- Sore that doesnt heal Varicella U nusual bleeding T hickening of lump LIVE VACCINES: I ndigestion (VIMRY) O bserved change in wart or mole Varicella N aging cough Influenza (nasal spray) MMR Rotavirus SCREENINGS Yellow Fever Yearly at 50 yo: - Stool exam VACCINE for Infants and Toddlers - Digital rectal exam (PHirD 2,4,6 mos) - Prostate exam PHD (capitalized) are not just for 2, 4, 6 mos Breast Exam: while i and r will be for 2, 4, 6 mos - 7 days after menstruation (if regular) PCV 2, 4, 6 and 12 - Monthly like every 17th or 8th (if irregular Hib 2, 4, 6 and 12 or menopause) IPV 2, 4, 6 - Before starting birth control pills RV 2, 4, 6 Colonoscopy: Dtap 2, 4, 6 and 15 - Every 10 years starting at 50 yo Hep B birth, 1 and 6 Mammogram: MMR, VZV, Hep A 12 - Every year starting at 40 yo PAP Smear: - Every 3 years starting at 21 yo FOLIC ACID - No longer needed if 65 yo and above if PRLC B (I pronounce it as prolic B) previous results showed negative Peanut butter Rice Leafy Vegetable Cereals Beans CUSHINGS TRIAD (high ICP) THIAZIDE ADVERSE EFFECT WIB 4H Widening pulse pressure Hypokalemia Irregular respiration Hyponatremia Bradycardia Hyperuricemia Hyperglycemia BECKS TRIAD (Cardiac Tamponade) MDH FAT EMBOLISM SYNDROME Muffled heart sound PFRN (I pronounce it as phern) Distended Neck Veins Petechial rash Hypertension (Narrowed pulse pressure) Fever Neurologic changes BEERs CRITERIA (Bad for geria) Respiratory problem 4ABDOI Antipsychotics SUICIDE RISK Anticholinergic SAD PERSONS Antihistamine Sex Antihypertensive Age Benzodiazepines Depression Diuretics Prior history Opioids Ethanol/drug abuse Insulin Rational thinking loss Support system loss INTRAPARTUM FHR Organized plan (VEAL CHOP) No significant other Variable Cord compression/ prolapsed cord Sickness Early Head compression Acceleration OK (normal) Ventilator Associated Pneumonia Bundle Late Placental Insufficiency POSED PUD Prophylaxis SKIN CANCER Oral Care ABCDE Sedation Vacation Asymmetry Elevate HOB Border irregularity DVT Prophylaxis Color Changes Diameter of 6mm or larger FIRE SAFETY Evolving RACE Rescue SPINAL IMMOBILIZATION Alarm NSAIDS Confine Neurological Exam Extinguish Significant traumatic mechanism of injury Alertness PASS Intoxication Pull the pin Distracting Injury Aim the nozzle Spinal exam Squeeze the handle Sweep nozzle MAJOR DEPRESSION TB DRUGS SIGE CAPS HIP RH EO (hip rheo) Sleep disturbance Isoniazid hepatotoxic and peripheral neuritis Interest deficit Rifampin hepatotoxic Guilt Ethambutol ocular toxicity Energy deficit Concentration deficit Appetite STOOL CHARACTERISTICS Psychomotor retardation or agitation Small, dry, rocky, hard mass constipation Suicidality Light gray clay colored biliary obstruction Mucus/pus ulcerative or infectious colitis NSAIDs Greasy, foamy, foul, fatty chronic pancreatitis NGBH Black tarry upper GI bleeding Nephrotoxic Bright red bloody lower GI bleeding Gastrointestinal disturbance Blood on surface hemorrhoids Bleeding HTN/HF CELIAC DSE SULFA DRUGS No BROW Yes RCP CPFADS Barley Rice Crystalluria Rye Corn Photosensitivity Oats Potato Folic Acid deficiency Wheats Agranulocytosis Diarrhea Steven Johnsons syndrome INSULIN
CYSTITIS Rapid Regular NPH Long Acting
F BUSH Peak 1-3 2-4 4-12 none Frequency Onset Rapid 30 mins 1-1 2-4 Burning on urination Duration 3-5 6-8 16-24 24 Urgency Suprapubic discomfort Hematuria BELIEF IN DEATH 0-2 yo none PYLONEPRITIS 3-5 7o death is reversible NF2C 6-9 yo concrete finality of death nausea and vomiting 10-12 yo death is final and affects everyone Fever and chills 12 above adult level Flank pain Costovertebral tenderness
60/ (0.2 x no. of big boxes in ECG) BETA-lol betablockers ACE-pril Ace Inhibitor BMI ARB-sartan Angiotensin II receptor blocker (lbs/in2) x 703 METHOTREXATE: immunosuppressant, DROP FACTOR rheumatoid arthritis volume x drop factor Minutes LEVODOPA: Parkinsons. Bradykinesia
PARKLAND FORMULA (BURNS) METRONIDAZOLE: vaginal infection, CDiff,
Needed for 24 hours HPylori 4 x TBSA x kg Divided by two to get the volume needed for CDIFF: X broad spectrum antibiotics the first 8 hours (Ceftriaxone) and protom pump inhibitor
DOSE PROTON PUMP INHIBITORS: may cause
(desire/stock) x volume osteoporosis
BENZTROPINE: decreases Extrapyramidial
CONVERSION Syndrome (pseudoparkinsons, dystonia) 1 lb = 16 oz 1 oz = 30 mL FLUMENAZIL: antidote for benzodiazepine(lam, 1 cup = 8 oz pam) 1 tsp = 5mL Modafinil: stimulant ANTIDOTE NorE/Epinephrine: Phentolamine Low residue means avoid all high fiber Heparin: Protamine Sulfate Warfarin: Vit K Hemorrhoids: priority is pain Acetaminophen: Acetylcysteine Benzodiazepine: Flumenazil No NGT for gastric surgeries Malignant Hyperthermia: Dantrolene EPS: Benztropine My butterfly's name is Lupus SVT: Adenosine MononucLymph
MMR: not for gelatine and neomycin
Dairy are high in potassium and phosphorus
Aphasia-impaired communication Apraxia-loss of ability to perform learned movt Dysarthria-impaired speech Dysphagia-difficulty swallowing
TINEA CORPORIS: ringworm
Cardimilzem (-depine, diltiazem, verapamil) More volume, more pressure: volume in the vascular space then pressure (CVP or BP) except ACE-pril - do not decreases HR for some diseases
Fluoroquinolones(floxacin)-tendinitis (Achilles') concentration makes the numbers go up,
floten dilution makes the numbers go down: for Na, Hct and sp.gravity MyonepQt (-mycin: ototoxic and neprotoxic affects QT in ECG)
Speech by the Permanent Secretary, Ministry of Health, Community Development, Gender Elderly and Children, Dr. Mpoki m. Ulisubisya During Opening Ceremony of the Regional Programme Representative Group (Rprg)
Speech by the Permanent Secretary, Ministry of Health, Community Development, Gender Elderly and Children, Dr. Mpoki m. Ulisubisya During Opening Ceremony of the Regional Programme Representative Group (Rprg)
